Skip to main content
Log in

Interventionelle Kinderkardiologie

Interventional pediatric cardiology

  • CME Zertifizierte Fortbildung
  • Published:
Monatsschrift Kinderheilkunde Aims and scope Submit manuscript

Zusammenfassung

Perkutane Herzkatheterinterventionen haben sich neben den herzchirurgischen Verfahren zu einem wichtigen Eckpfeiler in der Behandlung angeborener Herzfehler etabliert. Sie kommen bereits im Neugeborenenalter zum Einsatz und können Operationen vor- und nachbereiten oder diese bei bestimmten Herzfehlern vollständig ersetzen. Herzkatheterinterventionen bei Kindern verteilen sich v. a. auf Verschlüsse intrakardialer Shunts, Ballondilatationen und Stent-Implantationen. Als neues Verfahren wurde in den letzten Jahren der perkutane Klappenersatz, v. a. im Bereich degenerierter Grafts in Pulmonalarterienposition, mit einer „stented valve“ sehr erfolgreich eingeführt. Spezielle Hybrideingriffe, die gemeinsam von Herzchirurg und Interventionist vorgenommen werden, z. B. in der Behandlung des hypoplastischen Linksherzsyndroms, erweitern das Spektrum zusätzlich. Die Zukunft wird zusätzlich neue schonendere, möglicherweise bioresorbierbare Materialien für Implantate und neue Implantationsverfahren bringen. Neben diesen spannenden Entwicklungen müssen jedoch auch die Langzeitergebnisse der aktuellen Behandlungsverfahren kritisch weiterverfolgt und die Interventionen ggf. angepasst werden.

Abstract

Percutaneous cardiac catheter interventions have become established as an important cornerstone in the treatment of congenital heart defects in addition to cardiac surgical procedures. They are even performed in newborns and can be used to prepare or to work-up operations and for certain cardiac defects they can even replace them completely. Cardiac catheter interventions in children mostly involve occlusions of intracardiac shunts, balloon dilatation and stent implantation. In recent years a new procedure, percutaneous valve replacement with a stented valve, was very successfully introduced in the treatment of degenerated grafts in pulmonary artery positions. Special hybrid interventions undertaken by cardiac surgeons together with interventionalists, e.g. in the treatment of hypoplastic left heart syndrome, have additionally extended the spectrum. The future will additionally bring a new milder, possibly bioresorbable material for implants and new implantation procedures. However, in addition to these exciting developments the long-term results of current treatment procedures must also be critically followed up and if necessary the interventions must be adapted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8
Abb. 9
Abb. 10
Abb. 11
Abb. 12

Literatur

  1. Schmaltz AA (2007) Leitlinien zur Diagnostik und Therapie in der Pädiatrischen Kardiologie. Elsevier, München

  2. Fischer G, Stieh J, Uebing A et al (2003) Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart 89:199–204

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Schubert S, Kainz S, Peters B et al (2012) Interventional closure of atrial septal defects without fluoroscopy in adult and pediatric patients. Clin Res Cardiol 101(9):691–700

    Article  PubMed  Google Scholar 

  4. Ewert P, Kretschmar O, Peters B et al (2004) Interventioneller Verschluss angeborener Ventrikelseptumdefekte – breitere Indikationsstellung dank neuer Implantate. Z Kardiol 93(2):147–155

    Article  CAS  PubMed  Google Scholar 

  5. Carminati M, Butera G, Chessa M et al (2007) Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J 28:2361–2368

    Article  PubMed  Google Scholar 

  6. Michel-Behnke I, Ewert P, Koch A et al (2011) Device closure of ventricular septal defects by hybrid procedures: a multicenter retrospective study. Catheter Cardiovasc Interv 77:242–251

    Article  PubMed  Google Scholar 

  7. Xing Q, Pan S, An Q et al (2010) Minimally invasive perventricular device closure of perimembranous ventricular septal defect without cardiopulmonary bypass: multicenter experience and mid-term follow-up. J Thorac Cardiovasc Surg 139(6):1409–1415

    Article  PubMed  Google Scholar 

  8. Galal MO, Hussain A, Arfi AM (2006) Do we still need the surgeon to close the persistently patent arterial duct? Cardiol Young 16(6):522–536

    Article  PubMed  Google Scholar 

  9. Habib G, Hoen B, Tornos P et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30(19):2369–2413

    Article  PubMed  Google Scholar 

  10. Rashkind WJ, Miller WW (1966) Creation of an atrial septal defect without thoracotomy. A palliative approach to complete transposition of the great arteries. JAMA 196:991–992

    Article  CAS  PubMed  Google Scholar 

  11. Rao PS (2007) Percutaneous balloon pulmonary valvuloplasty: state of the art. Catheter Cardiovasc Interv 69(5):747–763

    Article  PubMed  Google Scholar 

  12. Harrild DM, Powell AJ, Tran TX et al (2010) Long-term pulmonary regurgitation following balloon valvuloplasty for pulmonary stenosis risk factors and relationship to exercise capacity and ventricular volume and function. J Am Coll Cardiol 55:1041–1047

    Article  PubMed Central  PubMed  Google Scholar 

  13. Bacha EA, Kreutzer J (2001) Comprehensive management of branch pulmonary artery stenosis. J Interv Cardiol 14(3):367–375

    Article  CAS  PubMed  Google Scholar 

  14. Bergersen LJ, Perry SB, Lock JE (2003) Effect of cutting balloon angioplasty on resistant pulmonary artery stenosis. Am J Cardiol 91(2):185–189

    Article  PubMed  Google Scholar 

  15. Benson LN, Nykanen D, Freedom RM (1996) Endovascular stents in congenital heart disease. Prog Cardiovasc Dis 39(2):165–186

    Article  CAS  PubMed  Google Scholar 

  16. Mc Mahon CJ, El-Said HG, Grifka RG et al (2001) Redilation of endovascular stents in congenital heart disease: factors implicated in the development of restenosis and neointimal proliferation. J Am Coll Cardiol 38(2):521–526

    Article  Google Scholar 

  17. Daehnert I, Rotzsch C, Wiener M, Schneider P (2004) Rapid right ventricular pacing is an alternative to adenosine in catheter interventional procedures for congenital heart disease. Heart 90(9):1047–1050

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Ewert P, Bertram H, Breuer J et al (2011) Balloon valvuloplasty in the treatment of congenital aortic valve stenosis – a retrospective multicenter survey of more than 1000 patients. Int J Cardiol 149(2):182–185

    Article  CAS  PubMed  Google Scholar 

  19. Arora R, Mukhopadhyay S, Yusuf J, Trehan V (2007) Technique, results, and follow-up of interventional treatment of rheumatic mitral stenosis in children. Cardiol Young 17:3–11

    Article  PubMed  Google Scholar 

  20. Fruh S, Knirsch W, Dodge-Khatami A et al (2011) Comparison of surgical and interventional therapy of native and recurrent aortic coarctation regarding different age groups during childhood. Eur J Cardiothorac Surg 39(6):898–904

    Article  PubMed  Google Scholar 

  21. Ewert P, Abdul-Khaliq H, Peters B et al (2004) Transcatheter therapy of long extreme subatretic aortic coarctations with covered stents. Catheter Cardiovasc Interv 63:236–239

    Article  PubMed  Google Scholar 

  22. Lurz P, Coats L, Khambadkone S et al (2008) Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 117(15):1964–1972

    Article  PubMed  Google Scholar 

  23. McElhinney DB, Hellenbrand WE, Zahn EM et al (2010) Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 122(5):507–516

    Article  PubMed Central  PubMed  Google Scholar 

  24. Haas NA, Moysich A, Neudorf U et al (2013) Percutaneous implantation of the Edwards SAPIEN(™) pulmonic valve: initial results in the first 22 patients. Clin Res Cardiol 102(2):119–128

    Article  PubMed  Google Scholar 

  25. Galantowicz M, Cheatham JP, Phillips A et al (2008) Hybrid approach for hypoplastic left heart syndrome: intermediate results after the learning curve. Ann Thorac Surg 85:2063–2070

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. O. Kretschmar, S. Navarini, W. Knirsch geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. Kretschmar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kretschmar, O., Navarini, S. & Knirsch, W. Interventionelle Kinderkardiologie. Monatsschr Kinderheilkd 163, 69–83 (2015). https://doi.org/10.1007/s00112-014-3263-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00112-014-3263-x

Schlüsselwörter

Keywords

Navigation